Skip to main content
Erschienen in: International Journal of Behavioral Medicine 6/2015

01.12.2015

Health Status and Psychological Distress in Patients with Non-compaction Cardiomyopathy: The Role of Burden Related to Symptoms and Genetic Vulnerability

verfasst von: Corline Brouwers, Kadir Caliskan, Sven Bos, Jeanine E. Roeters Van Lennep, Eric J. Sijbrands, Willem J. Kop, Susanne S. Pedersen

Erschienen in: International Journal of Behavioral Medicine | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Non-compaction cardiomyopathy (NCCM) is a cardiomyopathy characterized by left ventricular tribeculae and deep intertrabecular recesses. Because of its genetic underpinnings and physical disease burden, noncompaction cardiomyopathy is expected to be associated with a lower health status and increase in pscyhological distress.

Purpose

This study determined the health status and psychological distress in NCCM patients. We also examined the potential contribution of genetic predisposition and cardiac symptoms to health status and distress in NCCM, by comparing NCCM patients with (1) patients with familial hypercholesterolemia (FH) and (2) patients with acquired dilated cardiomyopathy (DCM).

Methods

Patients were recruited from the Erasmus Medical Center, Rotterdam, The Netherlands. Using a case-control design, NCCM patients (N = 45, mean age 46.7 ± 15.1 years, 38 % male) were compared with 43 FH patients and 42 DCM patients. Outcome measures were health status (Short Form Health Survey-12), anxiety (Generalized Anxiety Disorder 7-item scale) and depression (Patient Health Questionnaire 9-item scale).

Results

NCCM patients showed significantly worse health status (Physical Component Score F(1,84) = 9.58, P = .003; Mental Component Score F(1,84) = 16.65, P < .001), anxiety (F(1,85) = 9.63, P = .003) and depression scores (F(1,82) = 5.4, P = .023) compared to FH patients, also after adjusting age, sex, comorbidity, educational level and time since diagnosis. However, NCCM patients did not differ from DCM patients (Physical Component Score F(1,82) = 2,61, P = .11; Mental Component Score F(1,82) = .55, P = .46), anxiety (F(1,82) = 1.16, P = .28) and depression scores (F(1,82) = 1,95, P = .17).

Conclusion

Cardiac symptoms are likely to play a role in the observed poor health status and elevated levels of anxiety and depressive symptoms in NCCM, whereas the burden of having a genetic condition may contribute less to these health status and psychological measures.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Jenni R et al. Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy. Heart. 2001;86(6):666–71.PubMedCentralCrossRefPubMed Jenni R et al. Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy. Heart. 2001;86(6):666–71.PubMedCentralCrossRefPubMed
2.
Zurück zum Zitat Maron BJ et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113(14):1807–16.CrossRefPubMed Maron BJ et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113(14):1807–16.CrossRefPubMed
3.
Zurück zum Zitat Paterick TE et al. Left ventricular noncompaction cardiomyopathy: what do we know? Rev Cardiovasc Med. 2010;11(2):92–9.PubMed Paterick TE et al. Left ventricular noncompaction cardiomyopathy: what do we know? Rev Cardiovasc Med. 2010;11(2):92–9.PubMed
4.
Zurück zum Zitat Towbin JA. Left ventricular noncompaction: a new form of heart failure. Heart Fail Clin. 2010;6(4):453–69. viii.CrossRefPubMed Towbin JA. Left ventricular noncompaction: a new form of heart failure. Heart Fail Clin. 2010;6(4):453–69. viii.CrossRefPubMed
5.
Zurück zum Zitat Aras D et al. Clinical features of isolated ventricular noncompaction in adults long-term clinical course, echocardiographic properties, and predictors of left ventricular failure. J Card Fail. 2006;12(9):726–33.CrossRefPubMed Aras D et al. Clinical features of isolated ventricular noncompaction in adults long-term clinical course, echocardiographic properties, and predictors of left ventricular failure. J Card Fail. 2006;12(9):726–33.CrossRefPubMed
6.
7.
Zurück zum Zitat Oechslin EN et al. Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol. 2000;36(2):493–500.CrossRefPubMed Oechslin EN et al. Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol. 2000;36(2):493–500.CrossRefPubMed
8.
Zurück zum Zitat Finsterer J, Stollberger C. Genetic heterogeneity of noncompaction. Chin Med J (Engl). 2007;120(18):1647. author reply 1648. Finsterer J, Stollberger C. Genetic heterogeneity of noncompaction. Chin Med J (Engl). 2007;120(18):1647. author reply 1648.
9.
Zurück zum Zitat Hoedemaekers YM et al. Cardiac beta-myosin heavy chain defects in two families with non-compaction cardiomyopathy: linking non-compaction to hypertrophic, restrictive, and dilated cardiomyopathies. Eur Heart J. 2007;28(22):2732–7.CrossRefPubMed Hoedemaekers YM et al. Cardiac beta-myosin heavy chain defects in two families with non-compaction cardiomyopathy: linking non-compaction to hypertrophic, restrictive, and dilated cardiomyopathies. Eur Heart J. 2007;28(22):2732–7.CrossRefPubMed
10.
Zurück zum Zitat Hoedemaekers YM et al. The importance of genetic counseling, DNA diagnostics, and cardiologic family screening in left ventricular noncompaction cardiomyopathy. Circ Cardiovasc Genet. 2010;3(3):232–9.CrossRefPubMed Hoedemaekers YM et al. The importance of genetic counseling, DNA diagnostics, and cardiologic family screening in left ventricular noncompaction cardiomyopathy. Circ Cardiovasc Genet. 2010;3(3):232–9.CrossRefPubMed
11.
Zurück zum Zitat Ichida F et al. Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome. Circulation. 2001;103(9):1256–63.CrossRefPubMed Ichida F et al. Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome. Circulation. 2001;103(9):1256–63.CrossRefPubMed
12.
Zurück zum Zitat Pauli RM et al. Ventricular noncompaction and distal chromosome 5q deletion. Am J Med Genet. 1999;85(4):419–23.CrossRefPubMed Pauli RM et al. Ventricular noncompaction and distal chromosome 5q deletion. Am J Med Genet. 1999;85(4):419–23.CrossRefPubMed
13.
Zurück zum Zitat McAllister M et al. The emotional effects of genetic diseases: implications for clinical genetics. Am J Med Genet A. 2007;143A(22):2651–61.CrossRefPubMed McAllister M et al. The emotional effects of genetic diseases: implications for clinical genetics. Am J Med Genet A. 2007;143A(22):2651–61.CrossRefPubMed
14.
Zurück zum Zitat Bishop KK. Psychosocial aspects of genetic disorders: implications for practice. Fam Soc: J Contemp Hum Serv. 1993;74(4):207–12. Bishop KK. Psychosocial aspects of genetic disorders: implications for practice. Fam Soc: J Contemp Hum Serv. 1993;74(4):207–12.
15.
Zurück zum Zitat Ware JE, Kosinski M, Keller SD. SF-12: an even shorter health survey. Med Outcomes Trust Bull. 1996;4(1):2. Ware JE, Kosinski M, Keller SD. SF-12: an even shorter health survey. Med Outcomes Trust Bull. 1996;4(1):2.
16.
Zurück zum Zitat Ware JE, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–33.CrossRefPubMed Ware JE, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–33.CrossRefPubMed
17.
Zurück zum Zitat Manea L, Gilbody S, McMillan D. Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9): a meta-analysis. CMAJ : Can Med Assoc J = J de l’Association Medicale Canadienne. 2012;184(3):E191–6.CrossRef Manea L, Gilbody S, McMillan D. Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9): a meta-analysis. CMAJ : Can Med Assoc J = J de l’Association Medicale Canadienne. 2012;184(3):E191–6.CrossRef
18.
Zurück zum Zitat Lowe B et al. Measuring depression outcome with a brief self-report instrument: sensitivity to change of the Patient Health Questionnaire (PHQ-9). J Affect Disord. 2004;81(1):61–6.CrossRefPubMed Lowe B et al. Measuring depression outcome with a brief self-report instrument: sensitivity to change of the Patient Health Questionnaire (PHQ-9). J Affect Disord. 2004;81(1):61–6.CrossRefPubMed
19.
Zurück zum Zitat Spitzer RL et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.CrossRefPubMed Spitzer RL et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.CrossRefPubMed
20.
Zurück zum Zitat Dear BF et al. Psychometric comparison of the generalized anxiety disorder scale-7 and the Penn State Worry Questionnaire for measuring response during treatment of generalised anxiety disorder. Cogn Behav Ther. 2011;40(3):216–27.CrossRefPubMed Dear BF et al. Psychometric comparison of the generalized anxiety disorder scale-7 and the Penn State Worry Questionnaire for measuring response during treatment of generalised anxiety disorder. Cogn Behav Ther. 2011;40(3):216–27.CrossRefPubMed
21.
Zurück zum Zitat Charlson ME et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRefPubMed Charlson ME et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRefPubMed
22.
Zurück zum Zitat Levey AS et al. ., A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461–70.CrossRefPubMed Levey AS et al. ., A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461–70.CrossRefPubMed
23.
Zurück zum Zitat Finsterer J. Left ventricular non-compaction and its cardiac and neurologic implications. Heart Fail Rev. 2010;15(6):589–603.CrossRefPubMed Finsterer J. Left ventricular non-compaction and its cardiac and neurologic implications. Heart Fail Rev. 2010;15(6):589–603.CrossRefPubMed
24.
Zurück zum Zitat Ingles J et al. Psychosocial impact of specialized cardiac genetic clinics for hypertrophic cardiomyopathy. Genet Med: Off J Am Coll Med Genet. 2008;10(2):117–20.CrossRef Ingles J et al. Psychosocial impact of specialized cardiac genetic clinics for hypertrophic cardiomyopathy. Genet Med: Off J Am Coll Med Genet. 2008;10(2):117–20.CrossRef
25.
Zurück zum Zitat Hamang A et al. Health status in patients at risk of inherited arrhythmias and sudden unexpected death compared to the general population. BMC Med Genet. 2010;11:27.PubMedCentralCrossRefPubMed Hamang A et al. Health status in patients at risk of inherited arrhythmias and sudden unexpected death compared to the general population. BMC Med Genet. 2010;11:27.PubMedCentralCrossRefPubMed
26.
Zurück zum Zitat Hamang A et al. Predictors of heart-focused anxiety in patients undergoing genetic investigation and counseling of long QT syndrome or hypertrophic cardiomyopathy: a one year follow-up. J Genet Couns. 2012;21(1):72–84.CrossRefPubMed Hamang A et al. Predictors of heart-focused anxiety in patients undergoing genetic investigation and counseling of long QT syndrome or hypertrophic cardiomyopathy: a one year follow-up. J Genet Couns. 2012;21(1):72–84.CrossRefPubMed
27.
Zurück zum Zitat Charron P et al. Genetic testing and genetic counselling in hypertrophic cardiomyopathy: the French experience. J Med Genet. 2002;39(10):741–6.PubMedCentralCrossRefPubMed Charron P et al. Genetic testing and genetic counselling in hypertrophic cardiomyopathy: the French experience. J Med Genet. 2002;39(10):741–6.PubMedCentralCrossRefPubMed
28.
Zurück zum Zitat Ingles J et al. Genetic testing for inherited heart diseases: longitudinal impact on health-related quality of life. Genet Med. 2012;14:749–52. Ingles J et al. Genetic testing for inherited heart diseases: longitudinal impact on health-related quality of life. Genet Med. 2012;14:749–52.
29.
Zurück zum Zitat McGorrian C et al. Family-based associations in measures of psychological distress and quality of life in a cardiac screening clinic for inheritable cardiac diseases: a cross-sectional study. BMC Med Genet. 2013;14:1.PubMedCentralCrossRefPubMed McGorrian C et al. Family-based associations in measures of psychological distress and quality of life in a cardiac screening clinic for inheritable cardiac diseases: a cross-sectional study. BMC Med Genet. 2013;14:1.PubMedCentralCrossRefPubMed
30.
Zurück zum Zitat Christiaans I et al. Quality of life and psychological distress in hypertrophic cardiomyopathy mutation carriers: a cross-sectional cohort study. Am J Med Genet A. 2009;149A(4):602–12.CrossRefPubMed Christiaans I et al. Quality of life and psychological distress in hypertrophic cardiomyopathy mutation carriers: a cross-sectional cohort study. Am J Med Genet A. 2009;149A(4):602–12.CrossRefPubMed
31.
32.
Zurück zum Zitat Verbeek DE et al. A review on the putative association between beta-blockers and depression. Heart Fail Clin. 2011;7(1):89–99.CrossRefPubMed Verbeek DE et al. A review on the putative association between beta-blockers and depression. Heart Fail Clin. 2011;7(1):89–99.CrossRefPubMed
33.
Zurück zum Zitat Mols F, Pelle AJ, Kupper N. Normative data of the SF-12 health survey with validation using postmyocardial infarction patients in the Dutch population. Qual Life Res : Int J Qual Asp Treat, Care Rehab. 2009;18(4):403–14.CrossRef Mols F, Pelle AJ, Kupper N. Normative data of the SF-12 health survey with validation using postmyocardial infarction patients in the Dutch population. Qual Life Res : Int J Qual Asp Treat, Care Rehab. 2009;18(4):403–14.CrossRef
34.
Zurück zum Zitat Irvine MJ, Logan AG. Is knowing your cholesterol number harmful? J Clin Epidemiol. 1994;47(2):131–45.CrossRefPubMed Irvine MJ, Logan AG. Is knowing your cholesterol number harmful? J Clin Epidemiol. 1994;47(2):131–45.CrossRefPubMed
35.
Zurück zum Zitat Mata N et al. Quality of life in a cohort of familial hypercholesterolemia patients from the south of Europe. Eur J Publ Health. 2012;23:262–8. Mata N et al. Quality of life in a cohort of familial hypercholesterolemia patients from the south of Europe. Eur J Publ Health. 2012;23:262–8.
36.
Zurück zum Zitat Seed M, Weir MR. Double-masked comparison of the quality of life of hypercholesterolemic men treated with simvastatin or pravastatin. Int Qual Life Multicenter Group Clin Ther. 1999;21(10):1758–70. Seed M, Weir MR. Double-masked comparison of the quality of life of hypercholesterolemic men treated with simvastatin or pravastatin. Int Qual Life Multicenter Group Clin Ther. 1999;21(10):1758–70.
37.
Zurück zum Zitat Stewart RA et al. Long-term assessment of psychological well-being in a randomized placebo-controlled trial of cholesterol reduction with pravastatin. LIPID Study Investigators Arch Int Med. 2000;160(20):3144–52. Stewart RA et al. Long-term assessment of psychological well-being in a randomized placebo-controlled trial of cholesterol reduction with pravastatin. LIPID Study Investigators Arch Int Med. 2000;160(20):3144–52.
38.
Zurück zum Zitat Weir MR et al. Comparison of the effects on quality of life and of the efficacy and tolerability of lovastatin versus pravastatin. The Quality of Life Multicenter Group. Am J Cardiol. 1996;77(7):475–9.CrossRefPubMed Weir MR et al. Comparison of the effects on quality of life and of the efficacy and tolerability of lovastatin versus pravastatin. The Quality of Life Multicenter Group. Am J Cardiol. 1996;77(7):475–9.CrossRefPubMed
39.
Zurück zum Zitat Hollman G et al. Quality of life in patients with familial hypercholesterolaemia. J Intern Med. 2002;251(4):331–7.CrossRefPubMed Hollman G et al. Quality of life in patients with familial hypercholesterolaemia. J Intern Med. 2002;251(4):331–7.CrossRefPubMed
40.
Zurück zum Zitat Andersen LK et al. Patients’ attitudes toward detection of heterozygous familial hypercholesterolemia. Arch Intern Med. 1997;157(5):553–60.CrossRefPubMed Andersen LK et al. Patients’ attitudes toward detection of heterozygous familial hypercholesterolemia. Arch Intern Med. 1997;157(5):553–60.CrossRefPubMed
Metadaten
Titel
Health Status and Psychological Distress in Patients with Non-compaction Cardiomyopathy: The Role of Burden Related to Symptoms and Genetic Vulnerability
verfasst von
Corline Brouwers
Kadir Caliskan
Sven Bos
Jeanine E. Roeters Van Lennep
Eric J. Sijbrands
Willem J. Kop
Susanne S. Pedersen
Publikationsdatum
01.12.2015
Verlag
Springer US
Erschienen in
International Journal of Behavioral Medicine / Ausgabe 6/2015
Print ISSN: 1070-5503
Elektronische ISSN: 1532-7558
DOI
https://doi.org/10.1007/s12529-015-9475-1

Weitere Artikel der Ausgabe 6/2015

International Journal of Behavioral Medicine 6/2015 Zur Ausgabe